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 2 
Abstract 36 
 37 
Reduced energy intake drives weight loss following Roux-en-Y gastric bypass (RYGB) and 38 
sleeve gastrectomy (SG) procedures. Post-operative changes in subjective appetite, taste, and 39 
smell and food preferences are reported and suggested to contribute to reduced energy 40 
intake. We aimed to investigate the prevalence of these changes following RYGB and SG and 41 
to evaluate their relationship with weight loss.  42 
 43 
98 patients post-RYGB and 155 post-SG from a single bariatric centre were recruited to a 44 
cross-sectional study. Participants completed a questionnaire, previously utilised in post-45 
operative bariatric patients, to assess the prevalence of post-operative food aversions and 46 
subjective changes in appetite, taste and smell. Anthropometric data were collected and 47 
percentage weight loss (%WL) was calculated. The relationship between food aversions, 48 
changes in appetite, taste and smell and %WL was assessed. The influence of time post-49 
surgery, gender and type 2 diabetes (T2D) were evaluated.  50 
 51 
Following RYGB and SG the majority of patients reported food aversions (RYGB=62%, 52 
SG=59%), appetite changes (RYGB=91%, SG=91%) and taste changes (RYGB=64%, SG=59%). 53 
Smell changes were more common post-RYGB than post-SG (RYGB=41%, SG=28%, p=0.039). 54 
No temporal effect was observed post-RYGB. In contrast, the prevalence of appetite changes 55 
decreased significantly with time following SG.  56 
 57 
Post-operative appetite changes associated with and predicted higher %WL post-SG but not 58 
post-RYGB. Taste changes associated with and predicted higher %WL following RYGB but not 59 
post-SG. There was no gender effect post-RYGB. Post-SG taste changes were less common in 60 
males (female=65%, males=40%, p=0.008). T2D status in females did not influence post-61 
operative subjective changes. However, in males with T2D, taste changes were less common 62 
post-SG than post-RYGB together with lower %WL (RYGB=27.5±2.7, SG=14.6±2.1, p=0.003). 63 
Further research is warranted to define the biology underlying these differences and to 64 
individualise treatments.  65 
 66 
Keywords: Obesity, Roux-en-Y gastric bypass, sleeve gastrectomy, appetite, taste, smell, food 67 
aversions, weight loss. 68 
69 
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Introduction 70 
 71 
Bariatric surgery is the most effective treatment for patients with severe obesity, leading to 72 
sustained weight reduction, improved obesity-associated co-morbidities and decreased 73 
mortality (Sjostrom, 2013). The most commonly performed bariatric procedures globally are 74 
the Roux-en-Y gastric bypass (RYGB) and the sleeve gastrectomy (SG), accounting for 45% and 75 
37% respectively of operations undertaken in 2013 (Angrisani et al., 2015). Observational 76 
studies and a limited number of randomised controlled studies suggest that RYGB and SG 77 
produce comparable health improvements in the short-term (Schauer et al., 2014; Sczepaniak, 78 
Owens, Shukla, Perlegos, & Garner, 2015). Other procedures, such as the adjustable gastric 79 
banding (AGB) are now less commonly performed (Angrisani et al., 2015). 80 
 81 
Eating behaviour is a key determinant of the pathogenesis of obesity and weight loss achieved 82 
following bariatric surgery (Manning, Pucci, & Batterham, 2015; Scott & Batterham, 2011). An 83 
energy intake that consistently exceeds energy expenditure leads to weight gain and 84 
eventually obesity (Berthoud, 2011). Obese individuals subjectively rate energy-dense foods 85 
as more pleasant compared to lean individuals (Rissanen et al., 2002). In addition, weight gain 86 
and obesity have been linked to a reduction in taste sensitivity and smell perception (Miras & 87 
le Roux, 2010; Patel, DelGaudio, & Wise, 2015; A. C. Shin, Townsend, Patterson, & Berthoud, 88 
2011). Furthermore, neuroimaging studies have revealed that obese subjects exhibit altered 89 
neural responses within reward regions in response to food cues (Atalayer et al., 2014; 90 
Rissanen et al., 2002). 91 
 92 
The gastrointestinal (GI) tract is established as a key regulator of energy and glucose 93 
homeostasis and it is now clear that changes in gut-derived signals as a consequence of 94 
altered GI anatomy following bariatric surgery play a key role in driving reduced energy intake 95 
and weight loss (Dirksen, Damgaard, et al., 2013; Manning et al., 2015; Scott & Batterham, 96 
2011). Following RYGB and SG patients report reduced hunger in the fasted state, increased 97 
post-meal satiety, changes in subjective taste and altered food preferences (Manning et al., 98 
2015; Scott & Batterham, 2011). For example, a recent prospective study of 30 patients 99 
undergoing SG reported a 68% decrease in energy intake 6 months post-surgery sustained at 100 
24 months post-surgery. 75% of patients in this study reported reduced preference toward 101 
sweet and fatty foods (Coluzzi et al., 2016). 102 
 103 
In order to assess changes in subjective taste following bariatric surgery Tichansky et al. 104 
developed a questionnaire comprised of 23 questions. They reported that subjective taste 105 
changes were more common post-RYGB than following AGB surgery (Tichansky, Boughter, & 106 
Madan, 2006). Subsequently, Graham and colleagues used Tichansky’s questionnaire in a 107 
cross-sectional study to evaluate taste changes following RYGB in patients who were a median 108 
19 months post-RYGB (Graham, Murty, & Bowrey, 2014). They added 10 additional questions 109 
assessing subjective changes in appetite, smell and food aversions. They found that 93% of 110 
patients reported a change in appetite, 73% a change in taste, 42% a change in smell and 73% 111 
developed food aversions. Additionally, they reported that patients who developed food 112 
aversions achieved higher absolute post-operative weight loss and greater reduction in body 113 
mass index (BMI) (Graham et al., 2014). Zerrweck et al. using the questionnaire from Graham 114 
et al., reported that appetite, taste, smell and food aversions were equally common following 115 
RYGB and SG at 10 months post-surgery (Zerrweck et al., 2015). However, it remains unclear 116 
 4 
whether these subjective changes in appetite, taste and smell are a consequence of weight 117 
loss per se or if they are mediated by bariatric procedure-dependent physiological changes. 118 
The subjective hedonic value of sweet foods has been shown to reduce following RYGB 119 
(Ochner et al., 2011; Ochner et al., 2012; Scholtz et al., 2014).  This effect was not observed 120 
in BMI-matched subjects following AGB, suggesting that post-RYGB hedonic responses to 121 
food change independent of weight loss (Scholtz et al., 2014).  122 
 123 
The impact of bariatric surgery on objectively assessed olfaction and taste sensitivity is 124 
controversial, in part due to methodological issues. There are reports of improved post-125 
operative taste sensitivity for sweet, salty, sour and bitter (Altun et al., 2016; Holinski, 126 
Menenakos, Haber, Olze, & Ordemann, 2015), no taste sensitivity changes (Pepino et al., 127 
2014) and improved olfactory sensitivity (Holinski et al., 2015). There is also a suggestion of a 128 
difference between RYGB and SG with improved olfactory sensitivity post-SG but not post-129 
RYGB (Jurowich et al., 2014).  130 
 131 
Taste and smell perception are complex processes, integrating a range of sensory, cognitive 132 
and hormonal signals (Cummings, 2015; Miras & le Roux, 2010). Gender, obesity, presence of 133 
T2D and nutritional status (vitamin B12 and zinc levels) have all been reported to impact upon 134 
gustatory and olfactory function (Bustos-Saldana et al., 2009; Deglaire et al., 2015; Fabian, 135 
Beck, Fejerdy, Hermann, & Fabian, 2015; Hwang, Kang, Seo, Han, & Joo, 2016). The tendency 136 
to like fatty and salty tasting foods has been shown to have a linear relationship with 137 
increasing BMI in both males and females (A. C. Shin et al., 2011). However, a liking for sweet 138 
foods is more commonly reported by obese females compared to obese males (Deglaire et 139 
al., 2015) and females outperform males in their ability to detect certain odours (Doty & 140 
Cameron, 2009). T2D per se has been linked to impaired taste sensitivity, particularly for 141 
sweet stimuli and to impaired olfaction (Bustos-Saldana et al., 2009). Following RYGB, 142 
patients with T2D loose significantly less weight compared to patients who do not have T2D 143 
(Courcoulas et al., 2015). However, there are no reports comparing the prevalence of changes 144 
in subjective appetite, taste or smell following bariatric surgery in people with T2D compared 145 
to people without T2D.  146 
 147 
Following RYGB and SG, circulating gut hormone levels are markedly altered and these 148 
changes are suggested to contribute to post-operative appetite changes (Yousseif et al., 2014). 149 
Patients with a poor response to surgery experience increased hunger and reduced satiety 150 
levels. In addition, an attenuated gut hormone response is seen in poor weight loss 151 
responders compared to good weight loss responders (Dirksen, Jorgensen, et al., 2013; 152 
Manning et al., 2015). Interestingly, gut hormones are present in saliva and their cognate 153 
receptors are found on taste buds and olfactory neurons (Acosta et al., 2011; Cummings, 154 
2015; Loch, Breer, & Strotmann, 2015; Y. K. Shin et al., 2008). Hence, it is plausible that gut 155 
hormones mediate gustatory and olfactory changes following bariatric surgery through 156 
weight-independent mechanisms. Of note, RYGB and SG are anatomically very different and 157 
differentially impact upon circulating gut hormone levels (le Roux et al., 2007; Yousseif et al., 158 
2014). These differences may in turn result in post-procedural differences in appetite, taste 159 
and smell. Whilst the development of food aversions following SG and RYGB has been linked 160 
to increased weight loss, it remains to be established whether subjective change in appetite 161 
taste or smell associate with weight loss (Graham et al., 2014).  162 
 163 
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We hypothesized that post-operative subjective changes in appetite, taste and smell would 164 
differ between SG and RYGB patients and be influenced by gender and the presence of T2D. 165 
In addition that appetite, taste and smell changes would associate with post-operative weight 166 
loss. Thus, we aimed to investigate prevalence of appetite, taste, smell changes and food 167 
aversions following RYGB and SG and their relationship to post-operative percentage weight 168 
loss (%WL). We also aimed to evaluate the influence of gender, T2D and time post-surgery 169 
upon these changes.  170 
 171 
 172 
Methods  173 
 174 
Patients who attended the University College London Hospitals (UCLH) Bariatric Centre for 175 
Weight Management and Metabolic Surgery for follow up appointments after primary RYGB 176 
or primary SG were invited to participate. Participation was voluntary and informed consent 177 
was obtained in person by a healthcare professional. Ethical approval was obtained from the 178 
National Health Service Research Ethics Committee (ID#09/H0715/65) and the study was 179 
undertaken in accordance with the Helsinki Declaration. Inclusion criteria were adult patients 180 
(18 years or older), following either primary RYGB or SG and proficient in spoken and written 181 
English.  182 
 183 
Prior to surgery all patients had been assessed by a multidisciplinary team and fulfilled the 184 
criteria outlined by the National Institute for Health and Care Excellence (NICE, 2014). In RYGB 185 
stomach size is reduced by the creation of a small gastric pouch (~ 20cm3), ingested nutrients 186 
pass rapidly from the gastric pouch directly into the mid-jejunum, bypassing the majority of 187 
the stomach, the duodenum and the proximal jejunum (Olbers, Lonroth, Fagevik-Olsen, & 188 
Lundell, 2003). In SG, 80-90% of the total stomach volume is removed by transecting along 189 
the greater curvature of the stomach (Abu-Jaish & Rosenthal, 2010), the remainder of the GI 190 
tract is left intact and nutrient follow the normal anatomical route. 191 
 192 
Weight was measured using a Walkthrough Platform by a trained health professional. 193 
Participants completed a 33-question questionnaire, developed by Tichansky et al., and 194 
modified by Graham et al. (Graham et al., 2014; Tichansky et al., 2006) (appendix). Permission 195 
to use the questionnaire was obtained (Graham et al., 2014). Clinical data including height 196 
and weight on the day of surgery and presence or absence of T2D and exclusion criteria were 197 
obtained from the patients’ clinical records. Vitamin B12 and zinc levels were measured by 198 
the UCLH Department of Clinical Biochemistry using a competitive immunoassay (Roche) and 199 
colorimetric assay (Randox) respectively, as part of routine post-surgical care. 200 
 201 
After RYGB or SG surgery, patients are advised to adhere to a soft diet for the first two post-202 
operative weeks, followed by a soft diet with gradual reintroduction of solid food. Patients 203 
start eating meals of normal textured food 7 weeks after surgery. Thus, in order to eliminate 204 
the effect of early post-operative dietary restriction and allow for their eating behaviour to 205 
be established, patients less than 90 days post-surgery were excluded. Patients with factors 206 
affecting gustatory (including low zinc and low vitamin B12 levels) or olfactory function or 207 
who suffered a severe or debilitating illness, active malignancy and pregnant women were 208 
also excluded.  209 
 210 
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Percentage weight loss (%WL) was calculated by the weight difference between the day of 211 
surgery and the day of questionnaire completion and expressed as percentage of the weight 212 
on the day of surgery. Data were analysed using GraphPad Prism version 6 and STATA 213 
statistical software version 13. Mean and standard error of mean (SEM) were calculated. 214 
Continuous data was assessed for normality using D’Angostino and Pearson omnibus 215 
normality test. Parametric (t-test or one-way analysis of variance (ANOVA) and non-216 
parametric tests (Mann-Whitney tests)) were used as appropriate. Chi-square tests were used 217 
for categorical data. Furthermore, linear regression analyses were performed. Significance 218 
was assumed below the 0.05 level.  219 
 220 
 221 
Results 222 
 223 
Patient demographics 224 
253 patients were included in the final analysis, 98 following RYGB and 155 post-SG. 37 225 
patients were excluded from the study due pregnancy (n=8), B12 and/or zinc deficiency (n=4), 226 
symptomatic hypoglycaemia (n=3), conversion of SG to RYGB (n=8), active malignancy (n=4), 227 
previous cranial radiotherapy (n=1), anosmia (n=2), intolerance to solid foods (n=2), severe 228 
illness or reduced mobility (n=4) and inability to read English (n=1). Out of the included 229 
patients, 199 (79%) were female and 54 (20%) male. The patient characteristics are presented 230 
in Table 1. The RYGB and SG groups had a similar age and BMI but %WL and time post-surgery 231 
were significantly greater in the RYGB group. 232 
 233 
Table 1: Patient characteristics  234 
 235 
 Age (years) BMI  
(kg/m2) 
%WL Time post-surgery 
(days) 
RYGB  
n=98 
(M=19, F=79) 
 
46.5 ±1.1 44.7 ± 0.7 25.6 ± 0.9 769 ± 53 
SG  
n=155 
(M=35, F=120) 
44.3 ± 1.0 46.1 ± 0.6 21.2 ± 0.8 593 ± 43 
p value 0.120 0.260 0.0001 0.001 
Mean age, Body Mass Index (BMI), percentage weight loss (%WL) and time post-surgery in patients following 236 
Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) 237 
 238 
Subjective changes in appetite, taste and smell post-surgery 239 
The majority of patients reported post-operative change in appetite (Figure 1A, Question 1). 240 
Changes in taste and to a lesser extent smell were observed following both RYGB and SG, as 241 
were the development of food aversions (Figure 1B, 1C and 1D). While there were no 242 
significant differences in appetite, taste and food aversions between the two groups, smell 243 
changes were significantly more common following RYGB compared to SG (RYGB=41%, 244 
SG=28%, p=0.039). 245 
 246 
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In view of evidence regarding difference in taste perception between males and females, we 247 
examined the influence of gender upon the frequency of reported appetite, taste and smell 248 
changes and development of food aversions. No significant differences were found when 249 
comparing responses of female and male patients following RYGB (Table 2). However, within 250 
the SG group, taste and smell changes were significantly more common in female compared 251 
to male patients (Table 2). Furthermore, men post-SG lost significantly less weight compared 252 
to men following RYGB (%WL: RYGB=26.7 ± 2.13, SG=18.7 ± 1.7 p=0.004) 253 
 254 
(Figure 1 here) 255 
 256 
Table 2: Gender differences in the prevalence of subjective appetite, taste, smell changes 257 
and food aversions 258 
 259 
 RYGB  Group 
(% of patients/number reporting 
post-surgery change) 
SG Group 
(% of patients/number reporting 
post-surgery change) 
 Females Males p value Females Males p value 
Appetite 
changes 
92.4% (73) 84.2% (16) 0.370 91.7% (110) 88.6% (31) 0.521 
Taste 
changes 
62.0% (49) 73.7% (14) 0.341 65% (78) 40% (14) 0.008 
Smell 
changes 
41.8% (33) 36.8% (7) 0.695 31.7% (38) 14.3% (5) 0.043 
Food 
aversions 
45.7% (49) 66.7% (12) 0.713 62.3%  (76) 45.7% (16) 0.062 
Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) 260 
 261 
Influence of time post-surgery upon subjective changes in appetite, taste, smell, food 262 
aversions and %WL 263 
In light of the cross-sectional nature of our study, we investigated the effect of time since 264 
surgery on patients reporting perceived changes in appetite, taste and smell (Table 3). 265 
Following RYGB, no differences were found in the frequency of changes in appetite, taste, 266 
smell and food aversions at different time points. In contrast, following SG, the prevalence of 267 
subjective appetite changes decreased after 3 years (Table 3). The prevalence of taste and 268 
smell changes also reduced with time post-SG but these failed to reach significance. Following 269 
RYGB, maximum %WL was achieved at 1-2 years post-surgery and was similar at 2-3 years 270 
and 3-5 years post-RYGB (Table 4). Maximum %WL following SG was also observed at 1-2 271 
years post-surgery and was comparable to that seen in the RYGB group. %WL decreased with 272 
time post-surgery in the SG group (Table 4). Comparison of 2-5 year %WL between the RYGB 273 
and SG groups revealed greater %WL post-RYGB (%WL; RYGB=26.2±1.3, SG=20.8 ±1.9, 274 
p=0.023). 275 
 276 
 277 
 278 
 279 
 280 
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Table 3: Effect of time post-surgery on the prevalence of food aversions, subjective 281 
changes in appetite, taste and smell changes  282 
 283 
RYGB Group 
Time post-
surgery 
Change in 
appetite 
Change in 
taste 
Change in smell Food aversions 
< 180 days 
(n=6) 
100.0% 50.0% 50.0% 66.7% 
180-364 days 
(n=24) 
83.3% 62.5% 45.8% 54.2% 
p value 0.468 0.458 0.855 0.709 
1-2 years 
(n=23) 
95.7% 73.9% 43.5% 65.2% 
p value 0.267 0.289 0.817 0.528 
2-3 years 
(n=16) 
100% 62.5% 31.3% 62.5% 
p value 0.202 0.795 0.292 0.879 
3-5 years 
(n=29) 
86.2% 62.1% 37.9% 65.5% 
p value 0.306 0.767 0.706 0.665 
   SG Group  
Time post-
surgery 
Change in 
appetite 
Change in 
taste 
Change in smell Aversions 
< 180 days 
(n=36) 
97.2% 75.0% 44.4% 58. 5% 
180-364 days 
(n=41) 
100.0% 65.9% 24.4% 68.3% 
p value 0.283 0.321 0.063 0.879 
1-2 years 
(n=27) 
88.9% 48.1% 14.8% 59.3% 
p value 0.072 0.065 0.067 0.485 
2-3 years 
(n=19) 
84.2% 57.9% 21.1% 52.6% 
p value 0.722 0.797 0.499 0.309 
3-5 years 
(n=32) 
78.1% 43.8% 28.1% 43.8% 
p value 0.001 0.110 0.056 0.068 
Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG). Fisher’s exact correlation, p values represent 284 
comparison of given time interval versus previous data. 285 
 286 
 287 
 288 
 289 
 290 
 291 
 292 
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 293 
 294 
Table 4: Weight loss at different time points following RYGB and SG 295 
 296 
Time post-
surgery 
%WL in RYGB patients %WL in SG patients 
< 180 days 18.8 ± 2.2 17.0  ± 1.0 
180-364 days  24.6 ± 1.4 23.1  ± 1.1 
1-2 years  27.4 ± 1.9 26.2  ± 1.9 
2-3 years 26.1 ± 1.9 19.9  ± 3.3  
3-5 years 26.3 ± 1.8 20.3  ± 2.1 
Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), percentage weight loss (%WL) 297 
 298 
Relationship between subjective changes in appetite, taste, smell, food aversion and %WL 299 
We investigated the relationship between post-operative changes in appetite, taste, smell, 300 
food aversions and %WL. In the RYGB group there was significant association between a 301 
change in taste and higher %WL (27.8 ± 1.0 vs. 23.1 ± 1.6, p=0.036). In the SG group a 302 
significantly higher %WL was detected in patients with a change in appetite (21.9 ± 0.8 vs. 303 
13.4 ± 3.1, p=0.006) and food aversions (22.6 ± 1 vs. 19.2 ± 1.3, p=0.032). However, there was 304 
no association between subjective taste changes and %WL. 305 
 306 
Table 5: %WL in patients with and without subjective changes in appetite, taste, smell and 307 
food aversion post-RYGB 308 
 309 
 Appetite Taste Smell Food aversion 
Change 25.8 ± 0.9 
n=89 
27.8 ± 1.0 
n=63 
26.3 ± 1.5 
n=40 
26.5 ± 1.1 
n=61 
No change 23.8 ± 3.2 
n=9 
23.1 ± 1.6 
n=35 
25.2 ± 1.1 
n=58 
24.2 ± 1.2 
n=37 
p value 0.435 0.036 0.595 0.111 
Roux-en-Y gastric bypass (RYGB), percentage weight loss (%WL) 310 
 311 
 312 
Table 6: %WL in patients with and without subjective changes in appetite, taste, smell and 313 
food aversion post-SG 314 
 315 
 Appetite Taste Smell Food aversion 
Change 21.9 ± 0.8 
n=141 
21.9 ± 1.0 
n=92 
21.7 ± 1.8 
n=43 
22.6 ± 1.0 
n=92 
No change 13.4 ± 3.1 
n=14 
20.3 ± 1.3 
n=63 
21.1 ± 0.9 
n=112 
19.2 ± 1.3 
n=63 
p value  0.006 0.520 0.772 0.032 
Sleeve gastrectomy (SG), percentage weight loss (%WL) 316 
 317 
Subjective changes in taste towards sweet and salty foods 318 
Patients were asked if they had experienced a change in their taste towards sweet and salty 319 
foods. They were asked separately if they had experienced an increase or decrease in the 320 
 10 
taste of sweet or salty tasting foods (Appendix: Questions 9, 10, 12 and 13). 87.8% of RYGB 321 
patients responded that their taste for sweet foods had either increased or decreased 322 
compared to 65.2% of SG patients (p=0.001). Changes in taste towards salty tasting foods 323 
were also significantly more common following RYGB (% of patients reporting change in taste 324 
towards salty tasting foods: RYGB =56.1, SG= 40.6%, p=0.020, Figure 2). 325 
 326 
Following RYGB, there were no gender differences in subjective taste change towards sweet 327 
foods (females 89% and males 84%, p=0.685). However, post-SG a change in taste towards 328 
sweet foods, either an increase or decrease, was significantly more common in females 329 
compared to males (females 70% and males 45%, p=0.009). 330 
 331 
(Figure 2 here) 332 
 333 
Influence of T2D 334 
T2D was present in 92 patients (53 RYGB and 39 SG). No differences were seen in the 335 
prevalence of subjective change in appetite, taste, smell or food aversion between individuals 336 
with and without T2D post-RYGB (appetite change: no T2D=93.3%, T2D=88.7%; taste change: 337 
no T2D=73.3%, T2D=56.6%, smell change: no T2D=40%, T2D=41.5%; food aversions: no 338 
T2D=62.2%, T2D=62.3%; all p > 0.05) or post-SG (appetite change: no T2D=89.7%, T2D=94.9%; 339 
taste change: no T2D=62.1%, T2D=51.3%, smell change: no T2D=26.7%, T2D=30.8%; food 340 
aversions: no T2D=62.1%, T2D=51.3%; all p > 0.05). However, within the SG group, taste 341 
changes were significantly less common in males with T2D compared to females with T2D (% 342 
of patients reporting change in taste: T2D females=61.3%, T2D males=12.5%, p=0.020. 343 
Furthermore, taste changes were less common in males with T2D following SG than post-344 
RYGB (change in taste prevalence: T2D men RYGB=69.2%, T2D men SG=12.5%, p=0.024). 345 
Moreover, %WL was significantly lower in male T2D patients following SG compared to post-346 
RYGB (%WL: SG=14.6 ± 2.1, RYGB=27.5 ± 2.7, p=0.003).  347 
Table 7: Frequency of reported appetite, taste, smell changes and food aversions by gender 348 
in patients with T2D following RYGB and SG. 349 
 350 
 RYGB  SG  
 Females Males p value Females Males p value 
Appetite 87.5% 92.3% 0.370 96.8% 87.5% 0.372 
Taste 52.5% 69.2% 1.0 61.3% 12.5% 0.019 
Smell 42.5% 38.5% 1.0 35.5% 12.5% 0.393 
Food 
aversions 
65.0% 53.4% 0.522 58.1% 25% 0.123 
Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG) 351 
 352 
Predictors of weight loss 353 
Linear regression analyses were performed in order to correct for characteristics within 354 
groups and identify predictors of %WL. The models for RYGB and SG patients are illustrated 355 
in Table 8. The basic model (M1) adjusted for gender and days since surgery. Subjective taste 356 
changes following surgery were associated with greater %WL post-RYGB, even after adjusting 357 
for gender, age, duration since surgery and the presence of T2D. In contrast, post-SG, 358 
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subjective taste change was not related to %WL. However, in patients post-SG subjective 359 
change in appetite strongly associated with greater %WL after adjusting for gender, age, 360 
duration since surgery and T2D, which is not observed in RYGB. 361 
 362 
Table 8: Linear regression model testing %WL by appetite, taste, smell and aversions 363 
 364 
RYGB 
Model Appetite Taste  Smell Aversions  
 Coefficient 
 (95% CI) 
Coefficient  
(95% CI) 
Coefficient  
(95% CI) 
Coefficient 
(95% CI) 
Basic Model 
(M1) 
2.4 (-3.5; 8.4) 4.0 (0.5; 7.5)* 1.3 (-2.2; 4.9) 1.1 (-2.6; 4.8) 
M1 + age 2.5 (-3.4; 8.4) 3.6 (0.7; 7.1)* 1.1 (-2.4; 4.5) 0.9 (-2.7; 4.5) 
M1 + T2D 2.3 (-3.7; 8.3) 3.8 (0.2; 7.4)* 1.4 (-2.1; 4.9) 1.3 (-2.4; 4.7) 
  SG 
Model Appetite Taste Smell Aversions  
Basic Model 
(M1) 
8.1 (2.5; 13.7)** 0.9 (-2.5; 4.3) 0.1 (-3.5; 3.7) 3.1 (-0.1; 6.4) 
M1 + age 8.7 (3.2; 14.1)** 0.6 (-2.7; 3.9) 0.4 (-3.2; 3.9) 2.8 (-0.5; 5.9) 
M1 + T2D 8.9 (3.4; 14.5)** 0.5 (-2.8; 3.9) 0.3 (-3.2; 3.8) 2.8 (-0.4; 6.0) 
* p<0.05, ** p<0.01; Basic model adjusts for gender and days since surgery 
Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), Type 2 diabetes (T2D), M1 (Model 1) 365 
 366 
 367 
Discussion 368 
 369 
In this cross-sectional study we examined the prevalence of food aversions and subjective 370 
changes in appetite, taste and smell in a cohort of patients 6 months to 5 years following 371 
primary RYGB or SG. Our cohort included the largest SG group examined to date with the 372 
longest duration post-surgery. Our data show that whilst subjective changes in appetite, taste, 373 
smell and food aversions are common following both RYGB and SG they differ in their impact 374 
on subjective changes in smell and taste, durability of changes, influence of gender and 375 
relationship with %WL. 376 
 377 
In the RYGB group the prevalence of changes in appetite, taste, smell and food aversions was 378 
similar across all periods examined, with 86% of patients reporting appetite changes and 64% 379 
taste changes 3-5 years following RYGB. We observed no influence of gender or T2D status 380 
upon changes in appetite, taste or smell. %WL was similar at 1-2, 2-3 and 3-5 years post-381 
surgery. Linear regression analysis showed that subjective taste changes associated with and 382 
predicted %WL.   383 
 384 
After SG, smell changes were less common than after RYGB, as were also changes in taste 385 
towards sweet and salty tasting foods. The prevalence of changes in appetite significantly 386 
decreased with time post-surgery; the prevalence of changes in taste, smell and food aversion 387 
showed a trend to decrease with time post-surgery. Importantly, following SG the prevalence 388 
of changes in taste and smell was lower in males compared to females particularly in male 389 
patients with T2D. While %WL was comparable between RYGB and SG during the first post-390 
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operative 2-year period, between 2-5 years %WL was significantly greater in the RYGB group 391 
at 2-5 years post-surgery compared to the SG group. Subjective appetite changes associated 392 
with and predicted %WL in the SG group.  393 
 394 
Gender differences in taste sensitivity have been reported in obesity (Doty & Cameron, 2009; 395 
Hwang et al., 2016). Similarly, T2D, which is known to impact upon gut hormone profiles, has 396 
also been suggested to affect taste sensitivity, particularly toward sweet tasting foods 397 
(Bustos-Saldana et al., 2009). However, until now, no data existed with regards to effects of 398 
gender or T2D on appetite, taste or smell in patients following bariatric surgery. While no 399 
significant gender differences were seen within our RYGB group, there was a marked gender 400 
effect following SG. In particular, following SG the prevalence of taste changes was 401 
significantly lower in males with T2D compared to females with T2D. Moreover, the 402 
prevalence of taste changes and %WL were significantly lower in males with T2D following SG 403 
compared to RYGB. Our findings highlight the need for further research into the underlying 404 
physiology of these gender differences. 405 
 406 
The role of weight loss in mediating subjective changes in taste and smell remains to be 407 
clarified. Interestingly, reduced subjective taste and smell following GI surgery were first 408 
reported in normal weight patients as a transient complication following gastrectomy and 409 
oesophagectomy for GI malignancies (Harris & Griffin, 2003), suggesting that these changes 410 
are not restricted to people with obesity. In our cohort, the prevalence of smell changes was 411 
greater in the RYGB group compared to the SG despite comparable %WL during the first two 412 
post-operative years, suggesting weight independent processes may be involved. The 413 
perception of flavour is thought to be predominantly mediated through smell (Yeomans, 414 
2006), thus our findings of much higher prevalence of taste changes compared to smell 415 
changes following RYGB and SG is somewhat surprising. However, recent studies have 416 
identified gut hormone receptors on taste buds, gut hormones within saliva and postulated a 417 
role for saliva gut hormones in taste modulation (Acosta et al., 2011; Y. K. Shin et al., 2008). 418 
Circulating levels of gut hormones, in particular ghrelin, GLP-1 and PYY, change post-419 
operatively (Yousseif et al., 2014). Thus, these changes offer not only a plausible biological 420 
explanation for appetite changes post-surgery but also for the higher prevalence of taste 421 
compared to smell changes. In addition, the differential gut hormone pattern observed 422 
following RYGB and SG may underlie the procedural differences in appetite, taste and smell 423 
post-surgery (Cummings, 2015; Fabian et al., 2015). Longitudinal studies examining hormone 424 
levels in blood and saliva coupled with subjective and objective assessments of appetite, taste 425 
and smell in large cohorts of males and females undergoing RYGB and SG are now needed.  426 
 427 
Our study does have limitations. The study was cross-sectional, which resulted in a large 428 
variation in time post-surgery. Reported changes in appetite, taste and smell were subjective 429 
and no control group was included. In addition, since no data was collected pre-operatively, 430 
our data could be subject to recall bias, which is likely to increase with longer duration from 431 
surgery. Furthermore, the number of male participants in our study cohort was small. 432 
However, this reflects the higher number of females undergoing bariatric surgery in the UK 433 
compared to males (Wellbourn R, 2014).  Our findings of appetite, taste, smell changes and 434 
food aversions include the largest cohort of SG patients to date. Our SG sample size was larger 435 
compared to the RYGB group, while the post-RYGB patients had a significantly longer duration 436 
since surgery, which reflects the increasing popularity of SG over recent years and the trend 437 
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to perform a higher number SG (Angrisani et al., 2015). The higher %WL in the RYGB group is 438 
in concordance with previous findings from studies that have compared post-operative 439 
outcomes between RYGB and SG (Schauer et al., 2014; Sczepaniak et al., 2015). Similarly, 440 
weight loss post-RYGB was also higher compared to SG in the study conducted by Zerrweck 441 
et al (Zerrweck et al., 2015). The higher percentage of T2D in the RYGB population reflects 442 
that RYGB remains the preferred procedure in T2D, given the better T2D outcomes post-RYGB 443 
in the literature (Schauer et al., 2014). Graham et al. and Zerrweck et al. reported associations 444 
with food aversions and weight loss (Graham et al., 2014; Zerrweck et al., 2015). This effect 445 
was observed only following SG in our cohort.  However, the wording of the question relating 446 
to food aversions did not allow for a clear distinction between true food aversions, and post-447 
ingestive phenomena such as dumping syndrome. This ambiguity needs to be borne in mind 448 
when interpreting these results, as food tolerance and GI quality of life may play a role as 449 
aversive drivers of eating behaviour (Overs, Freeman, Zarshenas, Walton, & Jorgensen, 2012). 450 
Furthermore, feedback from our participants also highlighted the ambiguity of some of the 451 
questions, particularly relating to “increase” or “loss” of taste.  452 
 453 
Nevertheless, compared to previous studies, our study design has several strengths and 454 
provides novel findings. We obtained consent in person and completed data collection in one 455 
visit. Our exclusion criteria allowed for elimination of patients with additional factors that 456 
could impact on %WL, including low B12 and zinc. Furthermore, in contrast to previous 457 
studies we have used %WL as our outcome for weight loss, in order to avoid for confounding 458 
outcomes by pre-operative BMI. Our analysis identified procedure dependent differences in 459 
appetite, taste, smell changes and their impact upon %WL. In addition, we investigated the 460 
effect of gender and found marked gender differences within the SG group that are 461 
exacerbated by the presence of T2D. Finally, we performed linear regression analyses and 462 
thereby, for the first time, identified appetite and taste changes as predictors of %WL for SG 463 
and RYGB respectively.  464 
 465 
In conclusion, whilst subjective changes in appetite, taste, smell and food aversions are 466 
common following both RYGB and SG, marked differences between them exist in relation to 467 
the prevalence of changes in smell, taste, durability of changes, influence of gender and %WL. 468 
The presence of gender differences highlights the need to study comparable numbers of 469 
males and females. Furthermore, correlating gut hormone profiles with appetite and taste 470 
changes, will not only aid to further our understanding of the biological mediators for weight 471 
loss post-bariatric surgery allowing for personalised procedure allocation but may also lead 472 
to novel therapies, such as taste modulation approaches. 473 
 474 
 475 
 476 
 477 
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Figure Legends 484 
 485 
Figure 1: Frequency of reported appetite, taste, smell changes and food aversions following 486 
Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) 487 
 488 
A: Appetite changes (Q1) B: Taste changes (Q2) C: Smell changes (Q3) D: Food aversions (Q4) 489 
 490 
Figure 2: Change in taste toward sweet and salty foods 491 
  492 
Reported frequency of increased and decreased taste toward sweet (A) and salty (B) tasting 493 
foods in Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) respectively. 494 
 495 
496 
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Appendix 650 
 651 
Taste and smell questionnaire 652 
 653 
Please circle the most appropriate answer or circle the relevant number on the scale (1-654 
10)  655 
 656 
Q1. Have you noticed any change in your appetite since your weight loss surgery?  657 
 658 
YES/ NO  659 
 660 
Q2. Have you noticed any change in the taste of food or drink since your weight loss 661 
surgery?  662 
 663 
YES/ NO  664 
 665 
Q3. Have you noticed any change in your sense of smell since your weight loss surgery?  666 
 667 
YES/ NO  668 
 669 
Q4. Have you experienced an overall loss of taste since your weight loss surgery?  670 
 671 
YES/ NO  672 
 673 
 674 
If you answered YES to the above questions please continue. If you answered NO to all of 675 
the above questions, do not proceed any further. Please return the questionnaire.  676 
 677 
Q5. If you have had a loss of taste, is that loss:  678 
 679 
No loss   Partial    Complete  680 
 681 
1 2 3 4 5 6 7 8 9 10   682 
 683 
Q6. Are there any foods that are repulsive or intolerable to you since your weight loss 684 
surgery?  685 
 686 
YES/ NO  687 
 688 
If you answered yes then please state what:  689 
 690 
 691 
Q7. Are there any foods that taste different to you since your weight loss surgery?  692 
 693 
YES/ NO  694 
If yes, please state what food:  695 
 696 
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 697 
 698 
Q8. Has your overall taste increased in intensity since your weight loss surgery?  699 
 700 
YES/ NO  701 
 702 
 703 
Q9. Have you experienced an increase in taste for sweet foods?  704 
 705 
YES/ NO  706 
 707 
 708 
Q10. Have you experienced a decrease in taste for sweet foods?  709 
 710 
YES/ NO  711 
 712 
 713 
Q11. If you have had a loss of sweet taste, is that loss:  714 
 715 
No loss   Partial    Complete  716 
 717 
1 2 3 4 5 6 7 8 9 10   718 
 719 
 720 
Q12. Have you experienced an increase in taste for salty foods?  721 
 722 
YES/ NO  723 
 724 
 725 
Q13. Have you experienced a decrease in taste for salty foods?  726 
 727 
YES/ NO  728 
 729 
 730 
Q14. If you have had a loss of salty taste, is that loss:  731 
 732 
No loss   Partial    Complete  733 
 734 
1 2 3 4 5 6 7 8 9 10   735 
 736 
 737 
 738 
Q15. Have you experienced an increase in taste for sour foods?  739 
 740 
YES/ NO  741 
 742 
 743 
 21 
Q16. Have you experienced a decrease in taste for sour foods?  744 
 745 
YES/ NO  746 
 747 
 748 
Q17. If you have had a loss of sour taste, is that loss:  749 
 750 
No loss   Partial    Complete  751 
 752 
1 2 3 4 5 6 7 8 9 10   753 
 754 
 755 
Q18. Has this change in taste affected how much you eat?  756 
 757 
YES/ NO  758 
 759 
 760 
Q19. In your opinion, has your change in taste affected your weight loss?  761 
 762 
YES/ NO  763 
 764 
Q20. Overall, do you feel that your taste has increased or decreased in intensity  765 
since your weight loss surgery?  766 
 767 
Increased/ Decreased  768 
 769 
 770 
Q21. In your opinion, does loss of taste lead to better weight loss?  771 
 772 
YES/ NO  773 
 774 
 775 
Q22. Is your postoperative change in taste greater or less than what you expected 776 
preoperatively?  777 
 778 
Greater/ Less  779 
 780 
 781 
Q23. How important is taste to the enjoyment of food?  782 
 783 
Important/ Not important  784 
 785 
 786 
Q24. Have you experienced an overall loss in your sense of smell since your weight loss 787 
surgery?  788 
 789 
YES/ NO  790 
 22 
 791 
 792 
Q25. If you have had a loss of smell, is that loss:  793 
 794 
No loss   Partial    Complete  795 
 796 
1 2 3 4 5 6 7 8 9 10   797 
 798 
 799 
Q26. Are there any foods that smell differently to you since your weight loss surgery?  800 
 801 
YES/ NO  802 
 803 
If yes, please state what food?  804 
 805 
 806 
Q27. In your opinion, has your change in smell affected your weight loss?  807 
 808 
YES/ NO  809 
 810 
 811 
Q28. Overall, do you feel that your smell has increased or decreased in intensity since your 812 
weight loss surgery?  813 
 814 
Increased/ Decreased  815 
 816 
 817 
Q29. Is your postoperative change in smell greater or less than what you expected 818 
preoperatively?  819 
 820 
Greater/ Less  821 
 822 
 823 
Q30. How important is smell to the enjoyment of food?  824 
Important/ Not important  825 
 826 
 827 
Q31. Do you eat less food because it does not taste or smell good?  828 
 829 
YES/ NO  830 
 831 
 832 
 833 
Q32. Do you eat less food because you are simply not hungry?  834 
 835 
YES/ NO  836 
 837 
 23 
 838 
Q33. Is your postoperative change in appetite greater or less than what you expected 839 
preoperatively?  840 
 841 
Greater/ Less  842 
 843 
 844 
 845 
